نتائج البحث - "Alberto, Papi"

المساهمون: National Jewish Health, Fundación Cidea Allergy and Respiratory Research Unit, University of Oxford [Oxford], Università degli Studi di Ferrara (UniFE), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), German Centre for Lung Research, Partenaires INRAE, University of Missouri [Kansas City] (UMKC), University of Missouri System, Kindai University, Frankston Hospital, parent, Universitat Autònoma de Barcelona (UAB), Ajou University, University of Toronto, Sanofi [Bridgewater, NJ, USA], Regeneron Pharmaceuticals [Tarrytown], Sanofi Aventis R&D [Chilly-Mazarin]

المصدر: The Lancet Respiratory Medicine
The Lancet Respiratory Medicine, Elsevier, 2021, ⟨10.1016/S2213-2600(21)00322-2⟩

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Adult, Male, medicine.medical_specialty, Adolescent, [SDV]Life Sciences [q-bio], Socio-culturale, Moderate-to-severe asthma, Placebo, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Double-Blind Method, Internal medicine, dupilumab, medicine, Clinical endpoint, Humans, Anti-Asthmatic Agents, Adverse effect, non-oral-corticosteroids, Child, 030304 developmental biology, Asthma, Aged, Aged, 80 and over, 0303 health sciences, business.industry, exacerbation rate, Middle Aged, medicine.disease, Dupilumab, 3. Good health, Clinical trial, Treatment Outcome, 030228 respiratory system, Asthma Control Questionnaire, Moderate-to-severe asthma, dupilumab, non-oral-corticosteroids, exacerbation rate, Quality of Life, Bronchitis, Female, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::828a5b08dc17d4200d31d0d5511c4a7fTest
https://hal.archives-ouvertes.fr/hal-03363008Test

9

From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases

المؤلفون: Joseph K. Han, Florence Roufosse, Elisabeth H. Bel, Jonathan Steinfeld, Mark C. Liu, Ian D. Pavord, Oliver N. Keene, Steven W. Yancey, Alberto Papi, Arnaud Bourdin, Neil Martin, Michael E. Wechsler, Robert Chan

المساهمون: University of Oxford [Oxford], University of Amsterdam [Amsterdam] (UvA), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), GlaxoSmithKline (GSK), Eastern Virginia Medical School, University of Leicester, Università degli Studi di Ferrara (UniFE), Université libre de Bruxelles (ULB)

المصدر: Allergy
Allergy, Wiley, In press, ⟨10.1111/all.15056⟩

مصطلحات موضوعية: [SDV]Life Sciences [q-bio], medicine.medical_treatment, Immunology, Churg-Strauss Syndrome, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, 0302 clinical medicine, Adrenal Cortex Hormones, Eosinophilic, medicine, Immunology and Allergy, Humans, Anti-Asthmatic Agents, Pulmonary Eosinophilia, Interleukin 5, ComputingMilieux_MISCELLANEOUS, 030304 developmental biology, 0303 health sciences, business.industry, Hypereosinophilic syndrome, Granulomatosis with Polyangiitis, respiratory system, Eosinophil, medicine.disease, Asthma, 3. Good health, Clinical trial, Eosinophils, Cytokine, medicine.anatomical_structure, Treatment Outcome, 030228 respiratory system, Granulomatosis with polyangiitis, business, Mepolizumab, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd152db1248e099a7ce6cd383675637dTest
https://pubmed.ncbi.nlm.nih.gov/34402066Test

10

Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis

المؤلفون: Annalisa Stassaldi, Nunzio Crimi, Francesco Blasi, Gianluca Furneri, Francesca Fanelli, Giorgio Walter Canonica, Pierluigi Paggiaro, Alberto Papi

المصدر: Clinical and Molecular Allergy : CMA
Clinical and Molecular Allergy, Vol 19, Iss 1, Pp 1-11 (2021)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::197763728e242dc236ca316aaba79f4cTest
https://doi.org/10.1186/s12948-021-00146-9Test

تنقيح النتائج